SLC15A1 and familial pancreatic carcinoma: To assess whether PEPT1 could be used as a drug target to treat pancreatic cancer in vivo, mouse xenograft studies were performed in athymic nude mice using PEPT1-positive Capan-1 and SU.86.86 as the model cell lines.